Taylor Wessing advised Nuclera on the deal.Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, raised an additional $15.5 million in Series B…
Nuclera’s $15.5 Million Additional Capital Raise


Taylor Wessing advised Nuclera on the deal.Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, raised an additional $15.5 million in Series B…
…